Kemps-Polanco Reshema
SEC CIK 2009357 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CRL | Charles River Laboratories | Dir | 4,563 | — | — | 4 | 2024-02-01 | 2026-05-08 |
Most active insiders at CRL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FOSTER JAMES C | Dir | — | $34.84M |
| 2 | Parisotto Shannon M | CEVP, Disc, Safety Assessment | — | $2.97M |
| 3 | Girshick Birgit | COO, Corp. Executive VP | — | $1.82M |
| 4 | Knell Michael Gunnar | SVP, CAO, Fin | — | $1.73M |
| 5 | Creamer Victoria L | EVP, CHRO | — | $1.08M |
| 6 | Andrews Nancy C | Dir | — | $163.4K |
| 7 | LaPlume Joseph W | EVP, Corp Strategy, Develop | $4,364 | — |
| 8 | Mintz Mark | EVP, CIO | — | — |
| 9 | Kemps-Polanco Reshema | Dir | — | — |
| 10 | Barg Steven | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-11 16:30 | 2026-05-08 | CRL | Charles River Laboratories | Kemps-Polanco Reshema | Dir | A - Grant | $177.62 | +1,973 | 4,563 | +76% | +$350.4K |
| DM | 2025-05-23 | 2025-05-21 | CRL | Charles River Laboratories | Kemps-Polanco Reshema | Dir | A - Grant | $134.98 | +1,576 | 1,960 | +410% | +$212.7K |
| DM | 2024-05-15 | 2024-05-13 | CRL | Charles River Laboratories | Kemps-Polanco Reshema | Dir | A - Grant | $228.41 | +844 | 729 | New | +$192.8K |
| D | 2024-02-05 | 2024-02-01 | CRL | Charles River Laboratories | Kemps-Polanco Reshema | Dir | A - Grant | $0.00 | +170 | 170 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations